Venous Ulcer Treatment Market
Venous Ulcer Treatment Market by Diseases Type, Treatment Type, Distribution Channel & Region | Forecast 2023 to 2033
Market Insights on Venous Ulcer Treatment Market covering sales outlook, demand forecast and up-to-date key trends
Venous Ulcer Treatment Treatment Market Snapshot (2023 to 2033)
The global venous ulcer treatment market is expected to be valued at US$ 2.96 billion in 2023 and is projected to exhibit a compound annual growth rate (CAGR) of 6.5% from 2023 to 2033. At the end of the aforementioned forecast period, the market is poised to reach US$ 7.61 billion.
As per the NHS, venous ulcers are the most prevalent forms of leg ulcers, making up for more than 90% of all instances and affecting approximately 1 in 500 people in the UK. The increase in the frequency of venous ulcers and the emergence in the implementation of compression therapy to treat venous leg ulcers are the key determinants driving market expansion over the forecast period. Increasing awareness about the accessibility of therapeutic interventions for venous ulcers as well as breakthroughs in therapeutic approaches is expected to drive the venous ulcer treatment market growth throughout the forecast period.
Leg changes caused by venous ulcers are becoming progressively concerning for patients who are prone to blood clots, injury, and even weight gain. As a result, enterprises in the venous ulcer treatment industry are raising patient awareness about bio-skin treatments and inventive dressings. Doctors, on the other hand, are using technology tools including the leg ulcer measurement tool (LUMT) to examine different variables of leg ulcers and evaluate appropriate therapeutic indicators. Organizations in the venous ulcer treatment market are creating awareness about the use of electroceutical therapy to treat difficult-to-heal VLUs. Electrical stimulation and electroceuticals are widely publicized for their ability to reduce pain and swelling in patients, leading to higher clinical numbers.
In 2022, North America dominated the global venous ulcer treatment market. During the forecast timeframe, it is expected to dominate the market. During the forthcoming years, the European venous ulcer treatment market is expected to grow at an exponential rate. The prevalent use of wound care additives in several growing economies, including the United Kingdom, has obtained massive revenue over the decades. North America dominated the global market in 2022 and is expected to continue to do so throughout the forecast years. The regional market is growing as more people use technically advanced wound care items and therapeutic approaches, particularly negative pressure wound treatment. In the coming years, ongoing R&D on these will unlock new opportunities for revenue.
Treatment option advancements have been identified as an important venous ulcer treatment industry trend. Compression therapy has been shown in studies to shorten VLU recovery time and reduce the incidence rate. In addition, rigorous experiments by major competitors in compression therapy business development are rising sharply patient implementation. SIGVARIS, for instance, developed three inelastic compression items (COOLFLEX NF, COMPREFLEX REDUCE, and COMPREFLEX ARM.) for the diagnosis of venous ulcers in February 2018.
Considering the aforementioned facts and figures, the market is projected to exhibit a good rate of growth.
| Attribute | Details |
|---|---|
| Expected Market Value (2023) | US$ 2.96 Billion |
| Anticipated Forecast Value (2033) | US$ 7.61 Billion |
| Projected Growth Rate (2023 to 2033) | 6.5% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2018 to 2022 Venous Ulcer Treatment Demand Analysis vs. Forecast 2023 to 2033
During the coronavirus (COVID-19) pandemic, volunteer work organizations took the lead to provide venous ulcer effective treatments. For instance, the Tissue Viability Society, the leading oldest community outreach organization in the United Kingdom, took the lead to provide venous ulcer treatment methods during the coronavirus crisis by posting the most recent leg ulcer care knowledge on their official web page. During the historical context, a greater understanding of compression treatment methods ramped up revenue-generation procedures for organizations in the venous ulcer treatment market.
However, now, that the industries are getting back to their normal functioning, the global demand for Venous Ulcer Treatment is projected to increase at a CAGR of 6.5% during the forecast period between 2023 and 2033, reaching a total of US$ 7.61 billion in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 5.8%.
Which are Some Prominent Drivers of the Venous Ulcer Treatment Market?
The growing geriatric population drives market expansion
According to a report released by the National Library of Medicine, the overall incidence of this ailment is 1%, soaring to 3% among those over 65. Many advances in treatment and detection have occurred in the last 25 years.
Despite these advancements, curing response and chronicity remain variable, and venous ulcer remains a major complication. Based on a Pew Research Center report, the older populace of the United States will grow to 81 million by 2050, up from 37 million in 2005. As a result, this aspect is predicted to contribute to industry growth.
Treatment Options Developments to Provide Market-Thriving Growth
Burgeoning breakthroughs in treatment therapy are predicted to play a significant contribution to the venous ulcer treatment market growth over the coming years. Conventional therapeutic options have progressed into multi-component and two-layer compression therapy solutions, as well as short-stretch compression therapy systems.
This has improved the convenience of bandage implementation for practitioners while also supplying them with items that provide efficient therapeutic compression, which is anticipated to propel overall growth. Furthermore, the increase in the number of players involved in the creation of super-sophisticated products for the management of venous ulcers is inclined to fulfill the increasing demand for a robust solution for venous ulcers.
Find your sweet spots for generating winning opportunities in this market.
What are the Challenges Projected to be Faced by the Market?
High costs of ulcer management and a lack of knowledge about treatment options stifle market growth
The insufficient knowledge about venous ulcer therapeutic approaches in several developing countries is likely to stymie the expansion of the venous ulcer treatment market. Furthermore, the increased cost of ulcer management is expected to limit the market growth.
Nevertheless, proposals by government agencies and non-governmental institutions to spread awareness about the accessibility of novel therapeutic options in the market for venous ulcers, as well as diverse product releases, to broaden the product portfolio by several key players, are likely to create beneficial opportunities for growth in emerging regions.
Region-Wise Insights
What Makes North America the Largest Market for Venous Ulcer Treatment?
Presence of a Large Geriatric Population Base and Innovative Products Launch to drive regional market
The North American region is anticipated to rank second in the venous ulcer market. The enhanced launch of new products by prominent stakeholders is primarily contributing to the expansion of the venous ulcer market. In the United States, the pervasiveness of venous ulcers ranges from 1% to 3%. 2,3 Based on the AAFP organization, 10% to 35% of adults in the United States have prolonged venous insufficiency, and 4% of adults aged 65 and over have venous ulcers. As a result, this factor is anticipated to contribute to industry growth.
As a result, the USA government estimates that the older population will exceed 55 million by 2020, implying that chronic wounds will remain an increasingly chronic problem in this inhabitant which is also expected to drive the market growth.
Why is Europe Considered a Lucrative Region for the Venous Ulcer Treatment Market?
Europe dominates the market growth
Europe has a significant presence in the venous ulcer treatment market owing to its technological strength in terms of research and advancement. Furthermore, the increased incidences of venous ulcers in this region, as well as an expanding geriatric population, will aid in the expansion of the market in the United Kingdom.
Based on a paper released in 2019 by Age United kingdom, the United kingdom has approximately 12 million population aged 65 and above. Furthermore, venous ulcers are a widespread chronic condition in many countries, particularly in Europe. Up to 2.2 million people in Europe are impacted, which will contribute to the growth of the regional market during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Category-Wise Insights
Which Treatment Type Leads the Market for Venous Ulcer Treatment?
Compression therapy to hold dominant market share
The compression therapy segment is predicted to dominate the market for venous leg ulcer treatment. Several of the key drivers of the compression therapy segment's expansion are the emergence of advanced compression wound dressings and stockings for the treatment of venous ulcers, as well as the growing penetration of these commodities.
In addition, as patients become more conscious of the advantages of compression therapy, the use of compression therapy is expected to rise at a rapid pace. Furthermore, the segment is expected to maintain its dominance by broadening at an extremely rapid rate throughout the forthcoming years.
By Distribution Channel, Which Segment is Projected to Lead the Market?
Hospital Segment is Estimated to Hold the Largest Share
Due to the increase in hospitalization rates and hospital healthcare facilities, the hospital pharmacies segment is expected to capture a dominant share of the market throughout the forecast period. Furthermore, the same segment is expected to have the highest CAGR between 2023 and 2033.
Start-ups operating in the Venous Ulcer Treatment Landscape
- BioVenaTM, a first-of-its-kind efficacious non-thermal equipment that aids in the treatment of varicose veins and venous skin ulcers by stimulating the body's own recovery method, was launched by a Galway-based medical technology start-up. This device has bolstered the market for non-invasive therapeutic interventions for venous skin ulcers.
Market Competition
Key players in the Venous Ulcer Treatment market are Angiodynamics, Sigvaris Global, Medi GmbH & Co. KG, Activa Healthcare, 3M, Medtronic, Bristol Myers Squibb Co, Sanofi, Bayer AG, Pfizer Inc, Novo Nordisk A/S. Some of the latest developments are
- The Sigvaris ULCER X Wound Healing Compression Stocking Kit, which was introduced in September 2020, is a simple and advanced solution for treating acute venous conditions and intense leg ulceration.
- Medi GmbH & Co. KG launched circaid® for venous leg ulcer as an adjustable compression device for the rehabilitation of venous leg ulcers in February 2020.
Report Scope
| Attribute | Details |
|---|---|
| Expected Market Value (2023) | US$ 2.96 billion |
| Anticipated Forecast Value (2033) | US$ 7.61 billion |
| Projected Growth Rate (2023-2033) | 6.5% CAGR |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ Billion and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Key Segments Profiled in the Venous Ulcer Treatment Market Industry Survey
By Diseases Type:
- Arterial Ulcers
- Neurotropic Ulcer
- Venous Ulcers
- Diabetic Ulcers
By Treatment Type:
- Compression Therapy
- Surgical Therapy
- Skin Grafting
- Advanced Wound Dressing
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- South Asia
- East Asia
- Latin America
- Middle East and Africa
Frequently Asked Questions
What is the Venous Ulcer Treatment Market value in 2023?
The market in 2023 is valued at US$ 2.96 billion.
What is the market CAGR through 2033?
The market CAGR through 2033 is 6.5%.
Why is Europe considered a lucrative region for the market?
Europe is considered a lucrative region for the market because of its technological strength.
What is the market value for 2033?
By 2033, the market will reach US$ 7.61 billion.
What are the restraints for the market growth?
High costs of ulcer management and a lack of knowledge about treatment options stifle market growth.
Table of Content
1. Executive Summary | Venous Ulcer Treatment Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Diseases Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Diseases Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Diseases Type, 2023 to 2033 5.3.1. Arterial Ulcers 5.3.2. Neurotropic Ulcers 5.3.3. Venous Ulcers 5.3.4. Diabetic Ulcers 5.4. Y-o-Y Growth Trend Analysis By Diseases Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Diseases Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Treatment Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Type, 2023 to 2033 6.3.1. Compression Therapy 6.3.2. Surgical Therapy 6.3.3. Skin Grafting 6.3.4. Advanced Wound Dressing 6.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Treatment Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel , 2023 to 2033 7.3.1. Hospital Pharmacies 7.3.2. Retail Pharmacies 7.3.3. Online Pharmacies 7.4. Y-o-Y Growth Trend Analysis By Distribution Channel , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Distribution Channel , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Diseases Type 9.2.3. By Treatment Type 9.2.4. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Diseases Type 9.3.3. By Treatment Type 9.3.4. By Distribution Channel 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Diseases Type 10.2.3. By Treatment Type 10.2.4. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Diseases Type 10.3.3. By Treatment Type 10.3.4. By Distribution Channel 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Diseases Type 11.2.3. By Treatment Type 11.2.4. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Diseases Type 11.3.3. By Treatment Type 11.3.4. By Distribution Channel 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Diseases Type 12.2.3. By Treatment Type 12.2.4. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Diseases Type 12.3.3. By Treatment Type 12.3.4. By Distribution Channel 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Diseases Type 13.2.3. By Treatment Type 13.2.4. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Diseases Type 13.3.3. By Treatment Type 13.3.4. By Distribution Channel 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Diseases Type 14.2.3. By Treatment Type 14.2.4. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Diseases Type 14.3.3. By Treatment Type 14.3.4. By Distribution Channel 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Diseases Type 15.2.3. By Treatment Type 15.2.4. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Diseases Type 15.3.3. By Treatment Type 15.3.4. By Distribution Channel 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Diseases Type 16.1.2.2. By Treatment Type 16.1.2.3. By Distribution Channel 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Diseases Type 16.2.2.2. By Treatment Type 16.2.2.3. By Distribution Channel 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Diseases Type 16.3.2.2. By Treatment Type 16.3.2.3. By Distribution Channel 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Diseases Type 16.4.2.2. By Treatment Type 16.4.2.3. By Distribution Channel 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Diseases Type 16.5.2.2. By Treatment Type 16.5.2.3. By Distribution Channel 16.6. United kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Diseases Type 16.6.2.2. By Treatment Type 16.6.2.3. By Distribution Channel 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Diseases Type 16.7.2.2. By Treatment Type 16.7.2.3. By Distribution Channel 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Diseases Type 16.8.2.2. By Treatment Type 16.8.2.3. By Distribution Channel 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Diseases Type 16.9.2.2. By Treatment Type 16.9.2.3. By Distribution Channel 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Diseases Type 16.10.2.2. By Treatment Type 16.10.2.3. By Distribution Channel 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Diseases Type 16.11.2.2. By Treatment Type 16.11.2.3. By Distribution Channel 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Diseases Type 16.12.2.2. By Treatment Type 16.12.2.3. By Distribution Channel 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Diseases Type 16.13.2.2. By Treatment Type 16.13.2.3. By Distribution Channel 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Diseases Type 16.14.2.2. By Treatment Type 16.14.2.3. By Distribution Channel 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Diseases Type 16.15.2.2. By Treatment Type 16.15.2.3. By Distribution Channel 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Diseases Type 16.16.2.2. By Treatment Type 16.16.2.3. By Distribution Channel 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Diseases Type 16.17.2.2. By Treatment Type 16.17.2.3. By Distribution Channel 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Diseases Type 16.18.2.2. By Treatment Type 16.18.2.3. By Distribution Channel 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Diseases Type 16.19.2.2. By Treatment Type 16.19.2.3. By Distribution Channel 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Diseases Type 16.20.2.2. By Treatment Type 16.20.2.3. By Distribution Channel 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Diseases Type 16.21.2.2. By Treatment Type 16.21.2.3. By Distribution Channel 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Diseases Type 17.3.3. By Treatment Type 17.3.4. By Distribution Channel 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Angiodynamics 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Sigvaris Global 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Medi GmbH & Co. KG 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Activa Healthcare 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. 3M 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Medtronic 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Bristol Myers Squibb Co 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Sanofi 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Bayer AG 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Pfizer Inc 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Novo Nordisk A/S 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Paul Hartmann AG 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Europe Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 15: Europe Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033 Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: South Asia Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 19: South Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 20: South Asia Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033 Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: East Asia Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 23: East Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 24: East Asia Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033 Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: Oceania Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 27: Oceania Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 28: Oceania Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033 Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: MEA Market Value (US$ Million) Forecast by Diseases Type, 2018 to 2033 Table 31: MEA Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 32: MEA Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033 Figure 17: Global Market Attractiveness by Diseases Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Treatment Type, 2023 to 2033 Figure 19: Global Market Attractiveness by Distribution Channel , 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033 Figure 37: North America Market Attractiveness by Diseases Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Treatment Type, 2023 to 2033 Figure 39: North America Market Attractiveness by Distribution Channel , 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033 Figure 57: Latin America Market Attractiveness by Diseases Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Treatment Type, 2023 to 2033 Figure 59: Latin America Market Attractiveness by Distribution Channel , 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Europe Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 62: Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 63: Europe Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Europe Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 69: Europe Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 71: Europe Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 72: Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033 Figure 75: Europe Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033 Figure 76: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033 Figure 77: Europe Market Attractiveness by Diseases Type, 2023 to 2033 Figure 78: Europe Market Attractiveness by Treatment Type, 2023 to 2033 Figure 79: Europe Market Attractiveness by Distribution Channel , 2023 to 2033 Figure 80: Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: South Asia Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 82: South Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 83: South Asia Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: South Asia Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 89: South Asia Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 91: South Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 92: South Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 94: South Asia Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033 Figure 95: South Asia Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033 Figure 96: South Asia Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033 Figure 97: South Asia Market Attractiveness by Diseases Type, 2023 to 2033 Figure 98: South Asia Market Attractiveness by Treatment Type, 2023 to 2033 Figure 99: South Asia Market Attractiveness by Distribution Channel , 2023 to 2033 Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 101: East Asia Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 102: East Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 103: East Asia Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: East Asia Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 109: East Asia Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 111: East Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 112: East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 114: East Asia Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033 Figure 115: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033 Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033 Figure 117: East Asia Market Attractiveness by Diseases Type, 2023 to 2033 Figure 118: East Asia Market Attractiveness by Treatment Type, 2023 to 2033 Figure 119: East Asia Market Attractiveness by Distribution Channel , 2023 to 2033 Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 121: Oceania Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 122: Oceania Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 123: Oceania Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: Oceania Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 129: Oceania Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 131: Oceania Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 132: Oceania Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 134: Oceania Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033 Figure 135: Oceania Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033 Figure 136: Oceania Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033 Figure 137: Oceania Market Attractiveness by Diseases Type, 2023 to 2033 Figure 138: Oceania Market Attractiveness by Treatment Type, 2023 to 2033 Figure 139: Oceania Market Attractiveness by Distribution Channel , 2023 to 2033 Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 141: MEA Market Value (US$ Million) by Diseases Type, 2023 to 2033 Figure 142: MEA Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 143: MEA Market Value (US$ Million) by Distribution Channel , 2023 to 2033 Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: MEA Market Value (US$ Million) Analysis by Diseases Type, 2018 to 2033 Figure 149: MEA Market Value Share (%) and BPS Analysis by Diseases Type, 2023 to 2033 Figure 150: MEA Market Y-o-Y Growth (%) Projections by Diseases Type, 2023 to 2033 Figure 151: MEA Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 152: MEA Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 153: MEA Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 154: MEA Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 155: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 156: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 157: MEA Market Attractiveness by Diseases Type, 2023 to 2033 Figure 158: MEA Market Attractiveness by Treatment Type, 2023 to 2033 Figure 159: MEA Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 160: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
